Response to Letter to the Editor: Post-Vaccination Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine and Its Predictors in Pediatric Inflammatory Bowel Disease
Language English Country United States Media print-electronic
Document type Journal Article, Comment
PubMed
36913707
PubMed Central
PMC10171098
DOI
10.1097/mpg.0000000000003760
PII: 00005176-202306000-00030
Knihovny.cz E-resources
- MeSH
- COVID-19 * prevention & control MeSH
- Child MeSH
- Humans MeSH
- SARS-CoV-2 MeSH
- BNT162 Vaccine MeSH
- COVID-19 Vaccines * MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Comment MeSH
- Names of Substances
- BNT162 Vaccine MeSH
- COVID-19 Vaccines * MeSH
See more in PubMed
Kleebayoon A, Wiwanitkit V. Postvaccination Immunogenicity of COVID-19 vaccine in Pediatric Inflammatory Bowel Disease.: Comment. J Pediatr Gastroenterol Nutr. 2023. PubMed PMC
Bronsky J, Copova I, Durilova M, et al. . Post-vaccination immunogenicity of BNT162b2 SARS-CoV-2 vaccine and its predictors in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2023; 76:e36–e44. PubMed PMC
